Second-line Therapies in Advanced Hepatocellular Carcinoma Following First-Line Atezolizumab and Bevacizumab: Multicenter Single Institution Cohort Experience
ONCOLOGIST(2024)
Key words
hepatocellular carcinoma,second-line therapies,immunotherapy,anti-VEGF therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined